12125sek
-0,2 %
Date:2026-04-22Time:16:52:43Latest report:Q4-2025List:Mid CapTicker:BIOG B
Market Cap:12 261 msekEnterprise Value:11 460 msekNet Sales:1 538 msekEarnings:332,8 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:121,25
MA50:112,83
MA200:105,88
Price/MA200:14,5 %
RSI (14):61,1
Price/MA50:7,4 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.